HepaPredict

HepaPredict was founded in 2016 as a private spin-off from Karolinska Institutet, Stockholm, Sweden. Our ambition is to commission our scientific experience and expertise to deliver highest-quality science with the goal to support and optimize drug development efficacy and safety

Visit site